David Blaine Ridley
Associate Professor of the Practice of Business Administration
David Ridley is the Dr. and Mrs. Frank A. Riddick Associate Professor of the Practice of Business and Economics. He is also the Faculty Director of the Health Sector Management program at Duke University's Fuqua School of Business. In his research, David examines life sciences innovation and pricing. David was the lead author of a paper proposing the priority review voucher program to encourage development of drugs and vaccines for neglected diseases. It became law in the U.S. in 2007.
- Ph.D., Duke University 2001
- M.A., Duke University 1995
- B.A., University of Missouri at Columbia 1993
Ridley, DB. "Hotelling’s Law." In Palgrave Encyclopedia of Strategic Management,edited by D Teece and M Augier. 2013.
Towse, A, Keuffel, E, Kettler, HE, and Ridley, DB. "Drugs and Vaccines for Developing Countries." In The Oxford Handbook of the Economics of the Biopharmaceutical Industry. September 18, 2012. Full Text
Grabowski, HG, Ridley, David B., , Moe, and Jeffrey L., . "Encouraging innovative treatment of neglected diseases through priority review vouchers." In Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific,edited by K Eggleston,347-365. Stanford, CA: Stanford University: The Walter H, Shorenstein Asia-Pacific Research Center, September 1, 2009. Open Access Copy
Ridley, DB, and Régnier, SA. "The Commercial Market For Priority Review Vouchers." Health affairs (Project Hope) 35, no. 5 (May 2016): 776-783. Full Text
Ridley, DB, Dent, J, and Egerton-Warburton, C. "Efficacy of the Priority Review Voucher Program." JAMA 315, no. 15 (April 2016): 1659-1660. (Letter) Full Text
Regnier, SA, and Ridley, DB. "Market watch: Forecasting market share in the US pharmaceutical market." Nature reviews. Drug discovery 14, no. 9 (September 2015): 594-595. Full Text
Gans, JS, and Ridley, DB. "Innovation incentives under transferable fast-track regulatory review." Journal of Industrial Economics 61, no. 3 (September 1, 2013): 789-816. Full Text
Ridley, DB. "Payments, promotion, and the purple pill (Accepted)." Health Economics (United Kingdom) (2013). Full Text
Ridley, DB, and Sánchez, AC. "Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases." Lancet 376, no. 9744 (September 11, 2010): 922-927. Full Text